Skip to main content

MDWD · MediWound Ltd.

Track MDWD — free
$13.77 -0.03 (-0.22%) At close · Sep 30
Market Cap
$178.68M
Shares
12.91M
Volume · Sep 30 83.89K Avg daily vol (3M) 85.58K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$13.77 Open$13.80 Day$13.59–13.98 52W close$12.61–19.69 Avg vol 30d105K Short int1.8M · 14.0% float · 14.4d Short vol66% Last earningsAug 13, 2026 DataJan 2020–Sep 2026

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 5 wks
call held Aug 13, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+12.7%
Year over year
Operating margin
-149.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+18.9%
Year over year · more shares
Price change (1Y)
-23.2%
Trailing year
Short interest
14.0%
Latest settlement · 14.4 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol Moderate
Market backdrop VIX 16.3 · calm Equity put/call 0.53
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −13%
below
Price vs 50-day avg +1%
above
RSI (14) 53
neutral
MACD trend Positive
52-week position 16%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +9%
trailing
6-month return −23%
trailing
YTD return −25%
this year
Relative strength −35%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $14 › 200d $16 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +14 funds added
Insider flow Distributing
Net -$75.4K over 90 days · 67% sells
Short interest Rising
14.05% of float · ▲ +11.4% MoM · 14.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
78 holders — near 3-yr high, broad support
Squeeze score 85
high risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Moderate
Volatility 40%
annualized · 1-yr
Max drawdown −36%
past year
ATR 3.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jun 30, 2026
Full year 2026 revenue · full year 2026 Initiated $24M – $26M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−13% Bearish
Price vs 50-day avg
+1% Bullish
RSI (14)
53 Neutral
MACD trend
Positive Bullish
52-week position
16% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $14 › 200d $16 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +14 funds added
Insider flow Distributing
Net -$75.4K over 90 days · 67% sells
Short interest Rising
14.05% of float · ▲ +11.4% MoM · 14.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
78 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $13 Now $14 · 16% Range high $20
vs 200-day avg -13% vs 50-day avg +1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MDWD
MediWound Ltd.
this stock
$178.68M -25.4% — — 14.0%
VRTX
Vertex Pharmaceuticals Inc / Ma
$133.37B +15.3% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
$81.13B -1.8% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
$79.40B +553.0% +4.3% — 8.2%
CSLLY
Csl Ltd
$61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
78
% held
45.3%
Net QoQ
-248.6K sh
Top holder
INVESTOR AB
Held Float
View
Held by Funds
Fund positions
18
View
Short & Settlement
Short Interest Rising
Shares short
1.8M
Days to cover
14.4d
Change
+185.8K sh
View
Short Volume
Short vol %
66%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
21
Value
$275
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
40.0%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$75.4K
Buyers / Sellers
1 / 2
Buyers Sellers
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 13, 2026
This year
10
View
Proposed Sales
Value
$50.3K
Shares
4.0K
Filed
Aug 28, 2026
View
Exempt Offerings
Offering
$17.2M
Filed
Oct 6, 2022
View
Earnings & Events
Earnings Calls Upcoming
Next call
Oct 22, 2026
Last call
Aug 13, 2026
View
Investor Relations
Latest news
MediWound Awarded Additional $3.3…
Published
Sep 22, 2026
Upcoming events
4
View

Performance

5D 20D 120D MTD YTD
MDWD +0.9% +9.1% -22.5% +9.2% -25.4%
SPY -0.7% +0.1% +12.2% -0.6% +11.8%
vs SPY +1.6% +9.0% -34.7% +9.8% -37.3%
Key facts CIK 1593984 CUSIP M68830112 13F (30d) 3 filings 3 filers Visit website Investor relations